Skip to main content

Acquired factor VIII inhibitor in a nonhemophilia patient on hemodialysis: challenges in management

Buy Article:

$51.00 plus tax (Refund Policy)


It is well known that the uremic milieu predisposes patients to an increased risk of bleeding. We report a case of a patient on hemodialysis who developed recurrent unexplained bleeding episodes. His renal failure was secondary to systemic lupus erythematosus. Further investigations revealed that his bleeding was secondary to the development of acquired inhibitors to factor VIII: C following a flare up of his systemic lupus erythematosus. Management issues related to recurrent bleeding in this situation are discussed and reviewed.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Acquired Factor VIII inhibitor; SLE; hemodialysis; rFVIIa

Document Type: Case Report

Affiliations: Division of Nephrology, University Health Sciences Center, University of Missouri at Columbia, Columbia, MO, USA

Publication date: 2010-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more